Shuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31 PR Newswire ROCKVILLE, Md., Jan. 26, 2023 ROCKVILLE, Md. , Jan. 26, 2023 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced Anatoly Dritschilo , M.D., CEO, will present and host one-on-one meetings with investors...